A new drug shows promising results inhibiting metabolic pathways in the immune system. The work which was focused on limiting the metabolism of cancer cells appears to also work on T cells. T cells are the principle cells in our immune system. And lupus, a chronic autoimmune disease is caused by our own T cells attacking healthy cells in our bodies.
About 1.5 million Americans suffer from systemic lupus erythematosus, referred to as lupus, and 16,000 new cases get reported annually. Canada reports about 35,000 cases or 1 in 1,000 of the population. The disease is most common in people between the age of 15 and 45. It has been referred to as having “1,000 faces” because the symptoms vary dramatically and can be confused with other chronic diseases. Typically a person with lupus experiences:
Lupus patients report several different phases in the disease from flare ups to periods of chronic pain, swelling and rashes. Symptoms can disappear completely going into remission and then flare up again.
The treatment includes anti-inflammatory medication and steroids which have their own dramatic side affects.
The University of Florida team includes co-author Laurence Morel, Ph.D., Director of Experimental Pathology, at the university’s College of Medicine. The focus was on two things within T cells:
The energy state of immune cells is compromised when lupus occurs. They become hyper activated. So the researchers used two drugs to see if they could block the level of activity. The drugs are 2DG, short for 2-Deoxy-D-glucose, an experimental drug which targets glucose metabolism, and metformin, a commonly used drug for treating patients with Type 2 Diabetes. The application of these two reversed lupus in mice. In testing human T cells harvested from lupus patients,similar results were obtained with a noticeable slowing of cellular metabolism. In mice without lupus the two drugs had no affect on their T cells.
Dr. Morel believes this “may also open the door to targeting other metabolic pathways” replacing treatments for multiple sclerosis, Parkinson’s, Huntington and even Alzheimer’s. It is still no known whether the treatment will produce a complete cure for lupus. It will be a few more years before we will know.
What is an Autoimmune Disease?
Autoimmune diseases are inflammatory response diseases caused by our immune system attacking us. They are non-discriminating and can be found in almost every organ and system in the human body. They tend to be chronic conditions continuing throughout the lifetime of the individual. There can be periods of remission followed by reappearance of symptoms. They tend to strike women more than men. Hormones may play a role. But there are some autoimmune disorders that are more prevalent in men such as Type 1 Diabetes.
How significant is the problem? It is estimated that 24 million Americans and 5 percent of the population in Western countries suffer from autoimmune diseases. Compare that to cancer at 12 million Americans and you begin to see the enormity of the problem.
There appears to be a correlation between our genetic inheritance and autoimmune diseases with children tending to develop diseases that appear in parents, and close relatives exhibiting common autoimmune diseases within extended family groups. Multiple sclerosis represents one of the most common autoimmune diseases that tends to run in families.
What confounds the medical field today about autoimmune diseases is finding the smoking gun or guns, the direct causal link that triggers the immune system response. Lots of circumstantial evidence points to viruses, chemical exposure, foods and environmental toxins but doctors and researchers continue to investigate what triggers these diseases. Having a family member who continues to experience an autoimmune disease has made studying this subject very personal to me.
Autoimmune diseases attack every part of the body. The American National Institute of Health identifies at least 80 different autoimmune diseases that include many familiar conditions you probably never thought were caused by our immune system. See how many you know from this partial list.
Today’s Autoimmune Controls Create Their Own Problems
Currently autoimmune disease treatment is all about reducing or reversing symptoms. In the case of diabetes we treat sufferers with insulin rather than restore pancreatic cell function. In the case of many of the inflammatory responses from autoimmune diseases we treat patients with a cocktail of drugs that include prednisone and other corticosteroids, anti-inflammatories like aspirin, acid blockers, antihistamines and immune suppression drugs (the kind used to stop rejection in organ transplants). In many cases the side affects of these drug cocktails proves to be worse than the diseases.
HLA, T and B, Autoimmune Diseases and a Potential Cure
When scientists and researchers talk about the immune system the letters in the above title become part of the conversation.
What is HLA?
What does T refer to?
What is the B all about?
HLA stands for Human Leukocyte Antigen, the genes that reside on the 6th chromosome in our cells and that govern immune response. The proteins associated with these genes are called antigens.
The T and B refer to different types of leukocytes, the white blood cells that reside in our circulatory systems and marshal our response to infections. The T and the B refer to T-cells, and B-cells. In addition there are sub-categories to leukocyte groups. One is the T-regulatory cell or T-reg and researchers study it because these cells play a role in regulating the level of immune response by other leukocytes.
If we could develop a technology to stop specific unhelpful autoimmune reactions while allowing our normal immune response to deal with unwanted bacterium and viruses then we would be making a big leap forward in our ability to deal with autoimmune diseases. That’s exactly what researchers at the University of Calgary in Alberta, Canada, have been working on using nanotechnology as the delivery mechanism for a vaccine that cures Type 1 Diabetes and has implications for other autoimmune disorders.
Dr. Pere Santamaria works at the Julia McFarlane Diabetes ResearcherCentre in the University’s Faculty of Medicine.

Working with mice with Type 1 Diabetes, Dr. Santamaria and his team looked at stopping the autoimmune response that damages the pancreas leading to the condition. They studied the behaviour of specific T-cells responsible for the disease and the T-reg cells whose role is to inhibit the former from attacking healthy host tissue. Their goal was to strengthen the T-reg cells to stop the destructive autoimmune response. Using synthetic iron oxide nanoparticles and a cocktail of antigens from insulin producing cells, the team created a vaccine that could be directed at the autoimmune attack, strengthening the T-reg cells. The treatment not only restored normal blood sugar and insulin levels in the mice, it also prevented the onset of the disease. At the same time the vaccine treatment did not compromise the rest of the immune system.
The implication of using nanovaccines such as the one Dr. Santamaria’s team developed to treat other chronic autoimmune diseases is enormous. For those who suffer from one or more of that long list of autoimmune diseases described above, this is technology with great promise.
]]>